Global Cholangiocarcinoma Market Impelled by Increasing Prevalence of Liver Diseases

May 17, 2023 | Healthcare

The latest report by IMARC Group, titled "Cholangiocarcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2033," finds that the global cholangiocarcinoma market size is witnessing steady growth. Cholangiocarcinoma, also known as bile duct cancer, occurs in the cells that line the bile ducts inside and outside the liver. It is prevalent in people over the age of 50 and is more common in men than women. It can be caused due to various reasons, such as chronic inflammation of the bile ducts, primary sclerosing cholangitis, and infection with liver flukes. The most common symptoms of cholangiocarcinoma include jaundice, abdominal pain, weight loss, light-colored stool, nausea, vomiting, loss of appetite, fever, fatigue, and itching. It can be treated with surgery, radiation therapy, and chemotherapy, depending on the stage and location of cancer.

Global Cholangiocarcinoma Market Trends:

The market is primarily driven by the growing prevalence of liver diseases among individuals. Diseases such as primary sclerosing cholangitis, hepatitis C, and liver fluke infection are associated with the development of cholangiocarcinoma. In addition, the rising geriatric population, the increasing number of patients with liver disease, and the growing number of patients with diabetes are other major growth-inducing factors. Besides this, the introduction of advanced diagnostic technologies such as imaging, biomarker analysis, and genetic testing that assist in improving the early detection and diagnosis, monitoring tumor progression, assessing therapeutic response and clinical prognosis, and detecting recurrent tumors in patients with cholangiocarcinoma, thus contributing to the market growth. Moreover, professionals are developing effective therapies for the treatment of cholangiocarcinoma, including targeted therapies and immunotherapies. These therapies have the potential to improve the treatment landscape for cholangiocarcinoma, which can create a positive market outlook in the coming years. Furthermore, the increasing research and development activities conducted by key players are also propelling the market growth.

Market Summary:

  • The market has been bifurcated into in-market and late-stage pipeline cholangiocarcinoma drugs.
  • Region-wise, the market has been divided into the United States, Germany, France, the United Kingdom, Italy, Spain, and Japan. The United States has the largest patient pool for cholangiocarcinoma and represents the largest market for cholangiocarcinoma treatment.
  • The study also offers a thorough overview of the treatment practices for cholangiocarcinoma, the share of specific therapies, and the performance of key market players.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Cholangiocarcinoma Market Impelled by Increasing Prevalence of Liver Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More